Treatment

Treatment is determined by the type and stage of cancer, as well as by what treatments and services a patient chooses. The guidelines and other documents available here focus on topics related to the treatment of cancer in Ontario.

Multidisciplinary Cancer Conferences

Displaying Guidelines

166 Items

Indications for Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery

Document Status: Current
ID: GL 17-12
Version: N/A

Sep 2019

Kadcyla® Trastuzumab Emtansine Safety Reminder

Document Status: Current
ID: GL-C50-15

Jun 2014

Locoregional Management of In-Transit Metastasis in Melanoma

Document Status: Current
ID: GL 8-10
Version: N/A

Feb 2020

Management of Cancer Medication-Related Infusion Reactions

Document Status: Current
Version: 1

Aug 2019

Management of Ductal Carcinoma in Situ of the Breast

Document Status: Current
ID: GL1-10
Version: 4

Updated

Mar 2024

Management of Early-Stage Hodgkin Lymphoma

Document Status: Current
ID: GL 6-20
Version: 2

May 2023

Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Document Status: Current
ID: GL SCT-8

Oct 2017

Management of Squamous Cell Cancer of the Anal Canal

Document Status: Current
ID: 2-8
Version: 2

Feb 2014

Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and the American Society of Clinical Oncology Joint Guideline

Document Status: Current
ID: GL 1-23-A

Jul 2021

Managing System Pressures for Sarcoma Service Delivery in Ontario

Document Status: Current
ID: GL-C50-05

Jan 2009

Multidisciplinary Cancer Conference Standards

Document Status: Current
ID: MCC

Jun 2006

Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Document Status: Current
ID: GL 4-1
Version: 2

Jan 2021